CN110818864B - Preparation method of high-molecular antibacterial agent for improving antibacterial effect - Google Patents
Preparation method of high-molecular antibacterial agent for improving antibacterial effect Download PDFInfo
- Publication number
- CN110818864B CN110818864B CN201911143380.3A CN201911143380A CN110818864B CN 110818864 B CN110818864 B CN 110818864B CN 201911143380 A CN201911143380 A CN 201911143380A CN 110818864 B CN110818864 B CN 110818864B
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- polymer
- preparation
- materials
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 44
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 29
- 239000000178 monomer Substances 0.000 claims abstract description 29
- 239000001257 hydrogen Substances 0.000 claims abstract description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 26
- 230000003993 interaction Effects 0.000 claims abstract description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 4
- 229920000642 polymer Polymers 0.000 claims description 34
- 229920002635 polyurethane Polymers 0.000 claims description 11
- 239000004814 polyurethane Substances 0.000 claims description 11
- 230000000845 anti-microbial effect Effects 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 8
- 239000012986 chain transfer agent Substances 0.000 claims description 6
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000006184 cosolvent Substances 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000001302 tertiary amino group Chemical group 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 abstract description 14
- 241000894006 Bacteria Species 0.000 abstract description 13
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract description 4
- -1 N, N-dimethylamino Chemical group 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 5
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- IKJKDQWACJSGLT-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxycarbonylamino]ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)NCCOC(=O)C(C)=C IKJKDQWACJSGLT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012975 dibutyltin dilaurate Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 2
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 description 2
- 229920002946 poly[2-(methacryloxy)ethyl phosphorylcholine] polymer Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- VEUQNMYPKOMCTO-UHFFFAOYSA-N C(C(=C)C)(=O)OCCN(C)C(=O)OCCNCC Chemical compound C(C(=C)C)(=O)OCCN(C)C(=O)OCCNCC VEUQNMYPKOMCTO-UHFFFAOYSA-N 0.000 description 1
- HUQKHSAXGDMJMM-UHFFFAOYSA-N C(C(=C)C)(=O)OCCNC(=O)OCCN(CC)CC Chemical compound C(C(=C)C)(=O)OCCNC(=O)OCCN(CC)CC HUQKHSAXGDMJMM-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229920000469 amphiphilic block copolymer Polymers 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 150000001509 aspartic acid derivatives Chemical class 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
- C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/08—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing boron
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F220/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/04—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
- C08F230/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing boron
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2438/00—Living radical polymerisation
- C08F2438/03—Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2453/00—Characterised by the use of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives of such polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention provides a preparation method of a high-molecular antibacterial agent for improving antibacterial effect, which combines high-efficiency reaction in organic chemistry to prepare a methacrylate-based monomer or an acrylate-based monomer, wherein the small-molecular monomer comprises a carbamate element with hydrogen bond interaction, a tertiary amine element with antibacterial activity and a bacteria microenvironment responsive element. The invention endows the common material with antibacterial performance, and the existence of hydrogen bond interaction elements expands the application range of the macromolecular antibacterial agent.
Description
Technical Field
The invention relates to the technical field of biological materials, in particular to a preparation method of a high-molecular antibacterial agent for improving antibacterial effect.
Background
Bacteria are very ancient organisms, one of the main groups of organisms, and the most abundant of all organisms. Bacteria are ubiquitous, and are usually present wherever there is life. They are present in the air breathed, in the water drunk, and in the food eaten by humans. Bacteria can be carried by the airflow from one place to another. The human body is a habitat for a large number of bacteria; can be found on the skin surface, intestinal tract, oral cavity, nose and other body parts.
However, bacteria are an important source of human diseases, and their widespread existence disturbs human lives all the time, and their reproduction and variation threaten human health. The emergence and spread of bacterial resistance to traditional antibiotics has raised a threat to global medical safety. In daily life, people inevitably contact with various materials and become places for bacteria propagation and dissemination; such as various commodities, packaging, appliances, and utilities. Scientific development and improvement of the living standard of human beings lead the health consciousness of human beings to be continuously strengthened, and the application of antibacterial materials gradually draws more attention of people. In order to prevent the spread of bacteria, a plurality of functional materials with bacteriostasis and sterilization performance are produced, and the antibacterial materials can effectively improve the health level of people and benefit human beings. Existing antibacterial agents are roughly divided into three major groups: organic antibacterial agents, inorganic antibacterial agents, and natural antibacterial agents. However, organic antibacterial agents are poor in heat resistance and are easily washed away because of their inherently good water solubility; inorganic antibacterial agents such as nanosilver are release type antibacterial mechanisms, which are poor in stability and easily aggregated to limit antibacterial applications thereof. The natural antibacterial peptide widely existing in the autoimmune system of various cell organisms becomes a fuzz in the antibacterial agent due to its excellent antibacterial property. Thus, natural antimicrobial peptides, which are widely present in the autoimmune system of various cellular organisms, have become targets against which antimicrobial materials compete.
The natural antibacterial peptide is induced in vivo to produce a series of basic polypeptide substances with antibacterial activity, and the natural antibacterial peptide of the autoimmune system widely existing in multicellular organisms has broad-spectrum antibacterial property and also has antibacterial effect on drug-resistant bacteria. Domestic and foreign studies have shown that, in general, natural antimicrobial peptides produce antimicrobial activity by attacking the cytoplasmic membrane of bacteria. The mechanism of action of bacteria towards attacking the cytoplasmic membrane is more difficult to develop resistance than inhibition of bacterial metabolism. Most natural antimicrobial peptides are natural macromolecules with both electropositive and amphiphilic properties, which are critical to their antimicrobial activity. Electropositivity, such that the natural antimicrobial peptide binds to the negatively charged bacterial cell membrane surface by electrostatic complexation; the amphiphilicity endows the hydrophobic groups of the natural antimicrobial peptide with membrane breakage and penetration capabilities that promote subsequent antimicrobial activity.
However, the difficulty of extracting and separating the natural antibacterial peptide greatly limits the application of the natural antibacterial peptide to the antibacterial material. Therefore, there are many reports in the literature that polycationic natural-like antibacterial peptides such as poly-N-substituted lysine, poly-N-substituted aspartic acid, oligomer, and polymer have the same antibacterial activity as natural antibacterial peptides. To date, partially synthetic mimetic and antibacterialopeptides have entered clinical trials as antimicrobials or metabolic modulators. However, these antibacterial-mimetic peptides and antibacterial-like peptides are difficult to maintain their long-lasting antibacterial function because they are easily washed away by water due to their inherent high water solubility. In addition, the high water solubility also limits the affinity with common materials, and is difficult to blend with some of the most widely used high molecular materials such as polyurethane, polyamide and the like or form an effective antibacterial coating.
On the other hand, the antibacterial peptide mimics and antibacterial peptide analogues have high cytotoxicity because of high water solubility, so that the antibacterial peptide mimics and the antibacterial peptide analogues can be dissolved in a large amount in the presence of water. Therefore, its biocompatibility also limits its application in the field of antibacterial materials
Therefore, how to realize the controllable release and even the responsive release of the polymeric antibacterial agent is still a serious challenge and a problem to be solved under the condition of enhancing the material affinity and biocompatibility of the polymeric antibacterial agent and simultaneously ensuring the antibacterial activity of the material. Designing such an optimized antimicrobial system requires the introduction of new motifs and the application of a straightforward and efficient chemical structure design. .
Disclosure of Invention
In order to solve the defects of the prior art, the invention provides a preparation method of a high-molecular antibacterial agent for improving antibacterial efficacy, wherein hydrogen bond-containing elements are introduced into the high-molecular antibacterial agent, and the antibacterial property, the application range and the biocompatibility of the polymer are improved by adjusting the length of alkyl chains on electropositive tertiary amine elements, so that the antibacterial efficacy of the high-molecular antibacterial agent is improved.
In order to achieve the purpose, the invention adopts the technical scheme that:
a preparation method of a high-molecular antibacterial agent for improving antibacterial effect is used for preparing a methacrylate-based monomer or an acrylate-based monomer by combining with high-efficiency reaction in organic chemistry, wherein a small-molecular monomer comprises a carbamate element with hydrogen bond interaction, a tertiary amine element with antibacterial activity and a bacterial microenvironment responsive element, and has the following structure:
wherein R has 7 structures as above, and m, n =1 to 11.
The invention is further described by using polyethylene glycol (PEG-CTA) of the terminal group modified trithioester as a chain transfer agent, polymerizing the monomers by reversible addition-fragmentation chain transfer polymerization (RAFT) to obtain a block copolymer with controllable polymerization degree and polymerization degree distribution of the hydrophobic chain segment, and polymerizing the monomers by using micromolecular trithioester as a chain transfer agent to obtain a homopolymer.
As further described herein, the hydrophilic segment uses polyacrylic acid (PAA), poly (N-isopropylacrylamide) (PNIPAM), poly (2-methacryloyloxyethyl phosphorylcholine) (PMPC) or poly (N, N-dimethylaminoethyl methacrylate (PDMAEMA)) to obtain the corresponding amphiphilic block copolymer, also by RAFT polymerization.
The invention is further described, after the amphiphilic block polymer with proper hydrophilic and hydrophobic chain segment length obtained after optimization is dissolved by adopting a corresponding solvent, the polymer is formed into a film on the surfaces of other materials containing hydrogen bonds in a coating mode, so that the polymer and the materials are closely connected through hydrogen bond interaction.
The invention is further described by the following specific processes: the polymer is fully dissolved in the cosolvent, and then is uniformly sprayed on the surface of other materials or is mixed with organic solutions of other materials, and the polymer is obtained after the organic solvents are evaporated.
For further description of the present invention, the hydrogen bonding material is polyamide or polyurethane or cotton.
As a further description of the invention, acetone or dioxane or tetrahydrofuran is used as the co-solvent.
Compared with the prior art, the invention has the advantages that:
a hydrogen bond interaction element carbamate is introduced to a repeating structural unit of the structure of the high-molecular antibacterial agent, and alkyl chains with different lengths and structures are introduced to nitrogen of tertiary amine to regulate the pKa value of the tertiary amine and the water solubility of the whole molecule on the tertiary amine element playing an antibacterial role in the repeating structural unit. Hydrogen bond interaction elements such as a urethane bond, an amide bond and a urea bond are widely applied to the field of high polymer materials, and the hydrogen bond interaction elements endow high polymer materials such as nylon-66, polyurethane, protein, liquid crystal and the like with excellent performance.
Therefore, the introduction of hydrogen bond interaction elements can effectively improve the affinity of the antibacterial polymer and the commonly applied polymer material. The high molecular material can be dispersed and fused with other hydrogen bond-containing materials in modes of blending, surface coating and the like, so that the antibacterial property of the common material is endowed. The existence of hydrogen bond interaction elements expands the application range of the macromolecular antibacterial agent.
The alkyl chain length is regulated and controlled on the tertiary amine acting element on the high molecular antibacterial agent, the water solubility of the high molecular antibacterial agent is reduced along with the increase of the alkyl chain length, the reduction of the water solubility relatively slows down the release of the high molecular antibacterial agent, and on the contrary, the alkyl chain length on the tertiary amine acting element is reduced, the water solubility and the release of the high molecular antibacterial agent are also increased, so that the long-acting and durable antibacterial effect of the material is realized;
the polymer antibacterial agent which can responsively release the tertiary amine element with antibacterial activity is prepared, and the polymer antibacterial agent does not release the tertiary amine element with antibacterial function in an aseptic environment, so that the polymer antibacterial agent has good biocompatibility, but can responsively release the tertiary amine element with antibacterial activity in a bacterial microenvironment to kill bacteria; that is, only in the bacterial environment, the tertiary amine element with antibacterial activity on the polymer can be released to kill bacteria.
Drawings
FIG. 1 is the nuclear magnetic hydrogen spectrum of N, N-dimethylamino monomer, N-dimethylaminoethoxycarbonylaminoethyl methacrylate; nuclear magnetic hydrogen spectrum of N, N-diethylamino monomer, N-diethylaminoethoxycarbonylaminoethyl methacrylate; and the nuclear magnetic hydrogen spectrum of N, N-di-N-propylamino monomer, namely N, N-di-N-propylamine ethoxy carbonyl aminoethyl methacrylate.
FIG. 2 is a nuclear magnetic hydrogen spectrum of a monomer of N, N-diisopropylamino, namely N, N-diisopropylamino ethoxycarbonyl aminoethyl methacrylate; the nuclear magnetic hydrogen spectrum of the N-monosubstituted isobutylamino monomer, namely N-monosubstituted isobutylamino ethoxycarbonyl aminoethyl methacrylate; and nuclear magnetic hydrogen spectra of N, N-methylethylamino monomer, N-methylethylaminoethoxycarbonyl aminoethyl methacrylate.
FIG. 3 is a nuclear magnetic hydrogen spectrum of a hydrogen peroxide activated antimicrobial active monomer.
FIG. 4 shows an acid-base titration curve of a series of monomers such as N, N-dimethylamino monomer (N, N-dimethylaminoethoxycarbonylaminoethylmethacrylate), N-diethylamino monomer (N, N-diethylaminoethoxyoxycarbonylaminoethylmethacrylate), N-di-N-propylamino monomer (N, N-di-N-propylaminoethoxycarbonylaminoethylmethacrylate), N-diisopropylamino monomer (N, N-diisopropylaminoethoxyoxycarbonylaminoethylmethacrylate), N-monosubstituted isobutylamino monomer (N-monosubstituted isobutylaminoethoxycarbonylaminoethyl methacrylate), and N, N-methylethylamino monomer (N, N-methylethylaminoethoxycarbonylaminoethyl methacrylate).
FIG. 5 shows gel permeation chromatography spectra of a series of polymers such as N, N-dimethylamino polymer (i.e., N-dimethylaminoethoxyethyl methacrylate), N-diethylamino polymer (N, N-diethylaminoethoxycarbonyl aminoethyl methacrylate), N-methylethylamino polymer (N, N-methylethylaminoethoxycarbonyl aminoethyl methacrylate), N-diisopropylamino polymer (N, N-diisopropylaminoethoxycarbonyl aminoethyl methacrylate), and N-monosubstituted isobutylamino polymer (N-monosubstituted isobutylaminoethoxycarbonyl aminoethyl methacrylate)).
FIG. 6 is a transmission electron micrograph of an assembly formed after titration of a polymer of N, N-diisopropylamino group by acid base.
FIG. 7 is a graph depicting the antimicrobial activity of a series of nitrogen-substituted urethane polymers.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings, and it is to be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
In a first step, the following nitrogen-substituted urethane monomer M is prepared:
the tertiary amine element with antibacterial activity, the substitution of the tertiary amine is shown as the following figure:
the preparation method comprises the following steps: 20.0mmol of N-substituted tertiary aminoethanol was dissolved in 60mL of dry methylene chloride, followed by the addition of dibutyltin dilaurate (DBTL, 50-1000. Mu.L) as a condensation catalyst, and 22.0mmol of isocyanoethyl methacrylate was slowly added with stirring at 0 ℃ to 100 ℃. After 6 hours of reaction, the organic solvent was removed by rotary evaporation under reduced pressure (rotary evaporation), and the crude product was dissolved in methylene chloride, washed three times with saturated brine and dried over anhydrous magnesium sulfate. The crude product was then concentrated by rotary evaporation and purified by column chromatography (silica gel as the stationary phase packing and ethyl acetate as the mobile phase eluting solvent), then the organic solvent was removed by rotary evaporation and dried under vacuum to give pure white M (18.0 mmol, 90%).
In the second step, the following nitrogen-substituted urethane polymers were further prepared by RAFT polymerization:
a PEG (polyethylene glycol) chain segment is used as a hydrophilic chain segment, and the length of the chain segment can be randomly selected, such as x = 4-1000; the polymerization degree of the hydrophobic segment can be effectively changed by changing polymerization parameters and conditions, and specifically, y =2 to 250 is obtained, and the polymer (P1) in which x =60 and y =40 is selected is exemplified.
The preparation method comprises the following steps: 8mmol M monomer, 0.6g (0.26 mmol) PEG-CTA chain transfer agent and 10.6mg (0.064 mmol) Azobisisobutyronitrile (AIBN) initiator are dissolved in 1-100mL dioxane, added into a polymerization tube containing a magnetic stirrer, and placed in an oil bath at 0-100 ℃ after freeze-pumping circulation. The polymerization reaction is terminated after 12 hours by using a liquid nitrogen cooling mode, and after the room temperature is recovered, the reaction product is precipitated in anhydrous ether and repeatedly precipitated for three times. The product was dried in a vacuum oven to give polymer P1,2.56g (81.2%).
The third step: preparation of aqueous assemblies of nitrogen-substituted urethane polymers:
1) P1 was dissolved in 1 part by volume of an acidic aqueous solution (for example, an aqueous hydrochloric acid solution having a pH = 2), 9 parts of a weakly alkaline water was slowly added under stirring, and the pH of the system was adjusted to about 7.4, which is a normal physiological pH. The resulting whitish emulsion was placed in a dialysis bag and dialyzed against water until the acid-base neutralized salts were removed. This gave vesicles (V1) with a diameter of about 450nm, as visualized by TEM in FIG. 5.
2) P1 was dissolved in 1 part by volume of an organic solution (as exemplified by dioxane), and 9 parts of water were slowly added with stirring. The obtained whitish emulsion is placed in a dialysis bag and dialyzed in water until the organic solvent in the system is removed. This gave vesicles (V1) with a diameter of about 450nm, as visualized by TEM in FIG. 1.
Application example 1 antimicrobial activity characterization of nitrogen-substituted urethane polymers:
100 units of nitrogen-substituted polyurethane polymer and 200 parts of polyurethane are melted and blended, a film of 5 x 5cm is prepared after extrusion and granulation, and a series of antibacterial activity characterizations of the nitrogen-substituted polyurethane polymer are obtained after antibacterial tests are carried out according to relevant standards (the blank control is polyethylene glycol monomethyl ether, the molecular weight is 2000). The results show that: compared with a blank control, the nitrogen-substituted polyurethane polymer and the polyurethane material can be effectively blended, and the carbamate and the polyurethane material of the nitrogen-substituted polyurethane polymer can improve the affinity through the hydrogen bond-hydrogen bond interaction, so that the antibacterial durability is improved, which is consistent with the design expectation of the invention.
In the present embodiment, all the components are general standard components or components known to those skilled in the art, and the structure and principle thereof can be known to those skilled in the art through technical manuals or through routine experiments.
In the present invention, unless otherwise expressly stated or limited, "above" or "below" a first feature means that the first and second features are in direct contact, or that the first and second features are not in direct contact but are in contact with each other via another feature. Also, a first feature "above," "over," and "on" a second feature includes that the first feature is directly above and obliquely above the second feature, or merely means that the first feature is at a higher level than the second feature, and a first feature "below," "under," and "under" the second feature includes that the first feature is directly above and obliquely above the second feature, or merely means that the first feature is at a lower level than the first feature.
In the description of the present specification, reference to the description of the terms "one embodiment," "some embodiments," "an example," "a specific example" or "some examples" or the like means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention, and schematic representations of the terms in this specification do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
Although embodiments of the present invention have been shown and described above, it should be understood that the above embodiments are exemplary and not to be construed as limiting the present invention, and that those skilled in the art can make changes, modifications, substitutions and alterations to the above embodiments without departing from the principles and spirit of the present invention.
Claims (5)
1. A preparation method of a high-molecular antibacterial agent capable of improving antibacterial effect is used for preparing a methacrylate-based monomer or an acrylate-based monomer by combining with high-efficiency reaction in organic chemistry, wherein the methacrylate-based monomer or the acrylate-based monomer comprises a carbamate unit with hydrogen bond interaction, a tertiary amine unit with antibacterial activity and a bacterial microenvironment responsive unit, and is characterized by having the following structure:
wherein, R is tertiary amine element with antibacterial activity, has 6 structures as above, m, n = 1-11, polyethylene glycol with terminal group modified trithioester is used as chain transfer agent, reversible addition-fragmentation chain transfer polymerization (RAFT) is adopted to polymerize the monomer, and block copolymer with controllable polymerization degree of hydrophobic chain segment and polymerization degree distribution is obtained.
2. The preparation method of the polymeric antibacterial agent with the antibacterial effect improved according to claim 1, wherein after the obtained amphiphilic block polymer with the length of the hydrophilic and hydrophobic chain segments is dissolved by a corresponding solvent, the polymer is formed into a film on the surface of other materials containing hydrogen bonds in a coating mode, so that the polymer is tightly connected with the materials through the interaction of the hydrogen bonds.
3. The preparation method of the polymeric antibacterial agent with improved antibacterial effect according to claim 2 is characterized by comprising the following specific steps: the polymer is fully dissolved in the cosolvent, and then is uniformly sprayed on the surface of other materials or is mixed with organic solutions of other materials, and the polymer is obtained after the organic solvents are evaporated.
4. The method for preparing a polymeric antimicrobial agent with enhanced antimicrobial activity as claimed in claim 2, wherein the hydrogen bonding material is selected from polyamide, polyurethane or cotton.
5. The method as claimed in claim 3, wherein the co-solvent is acetone, dioxane or tetrahydrofuran.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911143380.3A CN110818864B (en) | 2019-11-20 | 2019-11-20 | Preparation method of high-molecular antibacterial agent for improving antibacterial effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911143380.3A CN110818864B (en) | 2019-11-20 | 2019-11-20 | Preparation method of high-molecular antibacterial agent for improving antibacterial effect |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110818864A CN110818864A (en) | 2020-02-21 |
CN110818864B true CN110818864B (en) | 2023-01-10 |
Family
ID=69557553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911143380.3A Active CN110818864B (en) | 2019-11-20 | 2019-11-20 | Preparation method of high-molecular antibacterial agent for improving antibacterial effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110818864B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113214587B (en) * | 2021-06-01 | 2022-06-03 | 浙江华帅特新材料科技有限公司 | Transparent, antibacterial organic glass and its manufacturing method |
CN118547388B (en) * | 2024-05-22 | 2024-10-18 | 南通金余纺塑有限公司 | Antibacterial acrylic fiber |
CN119119354A (en) * | 2024-08-23 | 2024-12-13 | 南方医科大学 | A choline polymer and its preparation method and application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105348294A (en) * | 2015-11-13 | 2016-02-24 | 中国科学技术大学 | Photochromic monomer, preparation method of photochromic monomer, amphiphilic polymer, preparation method of amphiphilic polymer, vesicle and use of vesicle |
CN109694483A (en) * | 2017-10-23 | 2019-04-30 | 江南大学 | A kind of antibacterial aqueous polyaminoester emulsion and preparation method |
CN109897148A (en) * | 2019-02-26 | 2019-06-18 | 西安交通大学 | Renewable polyureas-urethane of dynamic covalent cross-linking based on stable boric acid ester bond and its preparation and application |
-
2019
- 2019-11-20 CN CN201911143380.3A patent/CN110818864B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105348294A (en) * | 2015-11-13 | 2016-02-24 | 中国科学技术大学 | Photochromic monomer, preparation method of photochromic monomer, amphiphilic polymer, preparation method of amphiphilic polymer, vesicle and use of vesicle |
CN109694483A (en) * | 2017-10-23 | 2019-04-30 | 江南大学 | A kind of antibacterial aqueous polyaminoester emulsion and preparation method |
CN109897148A (en) * | 2019-02-26 | 2019-06-18 | 西安交通大学 | Renewable polyureas-urethane of dynamic covalent cross-linking based on stable boric acid ester bond and its preparation and application |
Also Published As
Publication number | Publication date |
---|---|
CN110818864A (en) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Dynamic covalent polymers for biomedical applications | |
Yu et al. | Ultrathin κ-carrageenan/chitosan hydrogel films with high toughness and antiadhesion property | |
CN110818864B (en) | Preparation method of high-molecular antibacterial agent for improving antibacterial effect | |
Chatterjee et al. | Stimuli-responsive hydrogels: An interdisciplinary overview | |
Ng et al. | Antimicrobial hydrogels: A new weapon in the arsenal against multidrug-resistant infections | |
Nagam et al. | A comprehensive review on hydrogels | |
US10023700B2 (en) | Hydrogel | |
García et al. | Interpenetrating polymer networks hydrogels of chitosan and poly (2-hydroxyethyl methacrylate) for controlled release of quetiapine | |
Sun et al. | Chitosan microparticles ionically cross-linked with poly (γ-glutamic acid) as antimicrobial peptides and nitric oxide delivery systems | |
Nayak et al. | Side‐chain amino‐acid‐based polymers: self‐assembly and bioapplications | |
Onder et al. | Preparation of synthetic polypeptide–polyhipe hydrogels with stimuli-responsive behavior | |
CN107513145A (en) | The synthesis of biodegradable amphiphilic block class antibacterial peptide and the preparation method and application of class antibacterial peptide vesica | |
Himi et al. | Preparation and evaluation of stomach specific IPN hydrogels for oral drug delivery: A review | |
Chauhan | Biocidal polymers | |
Raval et al. | Copolymers and block copolymers in drug delivery and therapy | |
CN106279635B (en) | Antibacterial peptides and vesicles and preparation methods and applications thereof | |
Wang et al. | Nanogel-reinforced polyacrylamide hydrogel for potential vascular adhesion | |
Camacho-Cruz et al. | Antimicrobial polymers | |
Khan et al. | Biomedical applications of interpenetrating polymer network gels | |
CN111269367A (en) | An acid-responsive charge shielding nanoparticle and its preparation method and application | |
CN101880398B (en) | Poly (L-glutamic acid-g-hydroxy-ethyl methacrylate) and hydroxy propyl cellulose-g-acrylic acid copolymer hydrogel and preparation method thereof | |
Ojha et al. | Hydrogels as potential controlled drug delivery system: drug release mechanism and applications | |
Suresh et al. | Chitosan based interpenetrating polymer network (IPN) hydrogels: a potential multicomponent oral drug delivery vehicle | |
CN106977674A (en) | A kind of pH response types antibacterial polymer nano particle and preparation method thereof | |
Farag et al. | Crosslinked polymer hydrogels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Shao Min Inventor after: Li Yang Inventor before: Shao Min |
|
GR01 | Patent grant | ||
GR01 | Patent grant |